2020

1. Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

   Blood Cancer Journal, Vol. 10, Núm. 10

2. Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

   Blood Cancer Journal, Vol. 10, Núm. 2